| __timestamp | Evotec SE | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17990000 | 1244910 |
| Thursday, January 1, 2015 | 25166000 | 5029636 |
| Friday, January 1, 2016 | 27013000 | 4846776 |
| Sunday, January 1, 2017 | 42383000 | 5329003 |
| Monday, January 1, 2018 | 57012000 | 7121000 |
| Tuesday, January 1, 2019 | 66546000 | 9128000 |
| Wednesday, January 1, 2020 | 77238000 | 10731000 |
| Friday, January 1, 2021 | 105445000 | 10701000 |
| Saturday, January 1, 2022 | 156190000 | 16121000 |
| Sunday, January 1, 2023 | 169610000 | 37021000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of two prominent biotech firms, Evotec SE and Viking Therapeutics, Inc., from 2014 to 2023. Over this period, Evotec SE's SG&A expenses surged by approximately 843%, reflecting its aggressive expansion and operational scaling. In contrast, Viking Therapeutics, Inc. exhibited a more modest increase of around 287%, indicating a more conservative growth strategy. Notably, in 2023, Evotec SE's SG&A expenses were nearly five times higher than those of Viking Therapeutics, highlighting the stark contrast in their financial strategies. This data provides valuable insights into how these companies allocate resources, offering a window into their strategic priorities and market positioning.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: SG&A Expense Trends
Selling, General, and Administrative Costs: argenx SE vs Evotec SE
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Evotec SE
Comparing SG&A Expenses: Alkermes plc vs Evotec SE Trends and Insights
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE